PL340555A1 - Preparations containing dissolved paroxetin - Google Patents

Preparations containing dissolved paroxetin

Info

Publication number
PL340555A1
PL340555A1 PL98340555A PL34055598A PL340555A1 PL 340555 A1 PL340555 A1 PL 340555A1 PL 98340555 A PL98340555 A PL 98340555A PL 34055598 A PL34055598 A PL 34055598A PL 340555 A1 PL340555 A1 PL 340555A1
Authority
PL
Poland
Prior art keywords
paroxetin
preparations containing
containing dissolved
dissolved
preparations
Prior art date
Application number
PL98340555A
Other languages
English (en)
Inventor
Ahmad Ghazawi
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PL340555A1 publication Critical patent/PL340555A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL98340555A 1997-11-21 1998-11-18 Preparations containing dissolved paroxetin PL340555A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation
PCT/GB1998/003471 WO1999026625A1 (fr) 1997-11-21 1998-11-18 Formulations contenant de la paroxetine dissoute

Publications (1)

Publication Number Publication Date
PL340555A1 true PL340555A1 (en) 2001-02-12

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98340555A PL340555A1 (en) 1997-11-21 1998-11-18 Preparations containing dissolved paroxetin

Country Status (24)

Country Link
EP (1) EP1033986A1 (fr)
JP (1) JP2001523718A (fr)
KR (1) KR20010032320A (fr)
CN (1) CN1279608A (fr)
AP (1) AP2000001821A0 (fr)
AR (1) AR015485A1 (fr)
AU (1) AU1168099A (fr)
BG (1) BG104527A (fr)
BR (1) BR9814220A (fr)
CO (1) CO4970832A1 (fr)
DZ (1) DZ2658A1 (fr)
EA (1) EA200000552A1 (fr)
GB (1) GB9724544D0 (fr)
HU (1) HUP0100580A3 (fr)
IL (1) IL136106A0 (fr)
MA (1) MA24704A1 (fr)
NO (1) NO20002590L (fr)
OA (1) OA11385A (fr)
PE (1) PE20000381A1 (fr)
PL (1) PL340555A1 (fr)
SK (1) SK7342000A3 (fr)
TR (1) TR200001423T2 (fr)
WO (1) WO1999026625A1 (fr)
ZA (1) ZA9810637B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
JP4854115B2 (ja) * 1999-03-12 2012-01-18 エイシカ ファーマシューティカルス リミテッド 無水パロキセチン用安定製剤形
KR100759159B1 (ko) 1999-07-01 2007-09-14 이탈파마코 에스.피.에이. 파록세틴과 사이클로덱스트린 또는 사이클로덱스트린유도체의 컴플렉스
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
ATE374602T1 (de) * 2001-12-21 2007-10-15 Supernus Pharmaceuticals Inc Orale kapselformulierung mit verbesserter physikalischer stabilität
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
WO2006119779A2 (fr) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S Composition pharmaceutique comprenant un antagoniste de l'aldosterone
US20120322752A1 (en) * 2009-12-08 2012-12-20 Sung Kyun Lee SOLID DISPERSIONS CONTAINING 20-O-beta-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0818990A1 (fr) * 1995-04-03 1998-01-21 Abbott Laboratories Melanges homogenes de medicaments fondant a basse temperature et d'additifs, destines a une liberation lente
EP0952831A1 (fr) * 1997-01-15 1999-11-03 Smithkline Beecham Plc Compositions a base de paroxetine

Also Published As

Publication number Publication date
NO20002590D0 (no) 2000-05-19
EA200000552A1 (ru) 2000-10-30
AP2000001821A0 (en) 2000-06-30
CO4970832A1 (es) 2000-11-07
HUP0100580A2 (hu) 2002-04-29
WO1999026625A1 (fr) 1999-06-03
MA24704A1 (fr) 1999-07-01
ZA9810637B (en) 2000-05-22
PE20000381A1 (es) 2000-05-07
JP2001523718A (ja) 2001-11-27
OA11385A (en) 2004-01-27
SK7342000A3 (en) 2000-12-11
CN1279608A (zh) 2001-01-10
IL136106A0 (en) 2001-05-20
KR20010032320A (ko) 2001-04-16
AU1168099A (en) 1999-06-15
DZ2658A1 (fr) 2003-03-22
GB9724544D0 (en) 1998-01-21
EP1033986A1 (fr) 2000-09-13
AR015485A1 (es) 2001-05-02
BR9814220A (pt) 2001-12-26
HUP0100580A3 (en) 2002-05-28
BG104527A (en) 2001-04-30
NO20002590L (no) 2000-07-19
TR200001423T2 (tr) 2000-10-23

Similar Documents

Publication Publication Date Title
GB2368979B (en) Adapters
GB2325840B (en) Heater-sensor complex
PL340075A1 (en) Strongly basic preparations containing hexylglyciside as a hydrothrope
PL334976A1 (en) Pharmaceutic preparations containing amoxycyclin and clavulate
PL337324A1 (en) Stable insulin preparations
ZA989538B (en) Single mould-half alignment
GB9715751D0 (en) Formulations
HUP0002127A3 (en) Syringe
EP0979660A4 (fr) Seringue
EP1074251A4 (fr) Preparations adhesives
SG76535A1 (en) Pharmaceutical agents
PL341604A1 (en) Local application ophthalmic preparations containing immunossuppressive agents
AU3089199A (en) Preparations containing licariin
PL340555A1 (en) Preparations containing dissolved paroxetin
GB9717883D0 (en) Vial
HUP0003038A3 (en) Low dosed 15-desoxyspergualine preparations
GB9813448D0 (en) Barrier preparations
GB9703676D0 (en) Stable system
IL136525A0 (en) Agents
HUP9903097A3 (en) Medicament containing progestogen-anti-progestogen
CA82556S (en) Capsule
GB9701325D0 (en) Sequence
GB9701179D0 (en) Sequence
GB9700730D0 (en) Sequence
GB9700871D0 (en) Sequence